These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4176451)

  • 21. [Experiences with the different dosage of Ovosiston preparations in the framework of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(2):61-4. PubMed ID: 4106277
    [No Abstract]   [Full Text] [Related]  

  • 22. Rate of secretion of corticosteroids in hamadryas baboons under normal conditions and following lengthy administration of chlormadinone acetate and mestranol.
    Goncharov NP
    Acta Endocrinol Suppl (Copenh); 1972; 166():428-32. PubMed ID: 4116113
    [No Abstract]   [Full Text] [Related]  

  • 23. [Our experiences in the inhibition of undesired lactation using Ovosiston].
    Kosowski I; Iliew D
    Zentralbl Gynakol; 1972 Aug; 94(34):1134-6. PubMed ID: 4116879
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of changes in erythrocyte and resin tests induced by the use of Femigen-forte and Femifen (Polfa) preparations as contraceptives].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1974 Jan; 45(1):57-60. PubMed ID: 4131322
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indications for the treatment with sequence preparations].
    Breckwoldt M; Bettendorf G
    Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE USE OF CHLORMADINONE IN GYNECOLOGICAL PRACTICE.
    CHARLES D; LORAINE JA; BELL ET; HARKNESS RA
    Am J Obstet Gynecol; 1964 Oct; 90():364-9. PubMed ID: 14212793
    [No Abstract]   [Full Text] [Related]  

  • 28. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation].
    Krzywdziński K; Jedrzejewski M; Teter J
    Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early tubal abortion during oral contraception].
    Köpernik H; Timmel H
    Zentralbl Gynakol; 1972 Sep; 94(38):1248-52. PubMed ID: 4118175
    [No Abstract]   [Full Text] [Related]  

  • 31. [Double blind test for induction of uterine hemorrhage by Ovulen (ethynodiol diacetate 0.5mg+mestranol 1.1mg])].
    Tanaka Y
    Sanfujinka No Jissai; 1970 Aug; 19(8):877-80. PubMed ID: 4917962
    [No Abstract]   [Full Text] [Related]  

  • 32. [Our method of treating Asherman's syndrome].
    Czekanowski R; Stelmachów J; Lasiewicki A; Zaremba R; Janiszewski W; Kapliński A
    Ginekol Pol; 1989 Jan; 60(1):33-7. PubMed ID: 2477313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management and evolution of endometrial hyperplasia using small doses of progestational hormones].
    Calderón JJ; García G; Maqueo M
    Ginecol Obstet Mex; 1969 Mar; 25(149):311-7. PubMed ID: 4181037
    [No Abstract]   [Full Text] [Related]  

  • 34. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum immunoglobulins and C-reactive protein following oral administration of ovulation inhibitors].
    Gay S; Seidenschnur G; Geiler G
    Dtsch Gesundheitsw; 1972 Jan; 27(1):32-4. PubMed ID: 4111064
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment for sterility (author's transl)].
    Schlosser H
    Zentralbl Gynakol; 1981; 103(19):1142-6. PubMed ID: 6171953
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral contraception and gynecologic therapy].
    Käsemann W
    Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Amenorrhea. Sterility. Ovarian dystrophy. Failure of surgical treatment. Success of treatment with gonadotropins of human origin].
    Mathieu J; Villedieu P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1967; 19(3):241-2. PubMed ID: 5584044
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen.
    Roland M; Clyman M; Decker A; Ober WB
    Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710
    [No Abstract]   [Full Text] [Related]  

  • 40. [Syndrome of amenorrhea and galactorrhea associated with sterility. Treatment with levodopa].
    García Núñez R; Fierro Villarreal OH; Thomas del Río G; Iduñate y Carlos DM; Hernández Ayup S
    Ginecol Obstet Mex; 1980 Oct; 48(288):255-9. PubMed ID: 7215900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.